The FDA began requiring clinical trials in 1962 with the Kefauver-Harris Amendments, which mandated that drug manufacturers prove both safety and effectiveness through adequate and well-controlled clinical investigations.
When did FDA start requiring clinical trials?
The FDA started requiring clinical trials in 1962 with the Kefauver-Harris Amendments, which mandated that drug manufacturers prove both safety and effectiveness through adequate and well-controlled clinical investigations.
The thalidomide tragedy of the early 1960s — thousands of birth defects worldwide — pushed Congress to act. Before 1962, FDA historians note, companies only had to show a drug was safe. The new law added a requirement for substantial evidence of effectiveness from controlled studies. That framework still underpins modern drug regulation today.
When was the first clinical trial?
The first documented clinical trial occurred in 1747 when James Lind conducted a controlled experiment on sailors with scurvy, though earlier examples like Ambroise Paré's 1537 battlefield wound comparison exist.
Lind's systematic comparison of six treatments for scurvy aboard HMS Salisbury is widely recognized as the first controlled clinical trial. Britannica describes how he allocated sailors to different remedies and observed that citrus fruits produced the most dramatic recovery. Honestly, that principle of controlled comparison remains the foundation of clinical research methodology.
Does FDA approval require clinical trials?
Yes, FDA approval for new drugs and biologics requires clinical trials conducted in multiple phases to demonstrate safety and effectiveness before market entry.
The agency evaluates data from Phase 1, 2, and 3 trials to assess benefits versus risks for the intended population. Mayo Clinic explains that while certain low-risk devices or generic drugs may follow abbreviated pathways, novel therapeutics must complete rigorous clinical testing. Sponsors who skip required trials face automatic rejection and potential legal consequences.
When did the FDA approval process start?
The modern FDA approval process began in 1906 with the Pure Food and Drugs Act, but the requirement for pre-market approval of new drugs was established in 1938 with the Federal Food, Drug, and Cosmetic Act.
The 1906 law focused on preventing adulterated and misbranded products. The 1938 act required manufacturers to submit safety data before marketing. FDA records show that the 1962 Kefauver-Harris Amendments then added the effectiveness requirement, creating the three-pillar standard (safety, efficacy, quality) used today. Subsequent legislation like the 1992 Prescription Drug User Fee Act accelerated review timelines.
What are the 4 phases of FDA approval?
The four phases of FDA approval are Discovery & Development, Preclinical Research, Clinical Research (Phases 1-3), and Post-Market Safety Monitoring (Phase 4).
Discovery involves target identification and compound screening, typically taking 2-5 years. Preclinical research uses laboratory and animal testing to assess toxicity. Clinical research progresses through three phases of human testing. NIH notes that Phase 4 surveillance continues after approval to detect rare or long-term adverse events. The entire process averages 10-15 years and costs over $2 billion per approved drug.
Can you be forced into a clinical trial?
No, you cannot be forced into a clinical trial; participation is always voluntary and you may withdraw at any time without penalty.
Federal regulations (HHS 45 CFR 46) require informed consent that explains risks, benefits, alternatives, and the right to refuse or quit. Institutional Review Boards (IRBs) oversee trials to protect participant rights. ClinicalTrials.gov reports over 439,000 active participants worldwide as of 2026, all enrolled voluntarily. Coercion or undue influence violates ethical standards and federal law.
Who runs clinical trials?
Clinical trials are typically sponsored by pharmaceutical companies, academic institutions, or government agencies like the NIH, and are conducted by investigators at research sites such as hospitals and clinics.
Sponsors fund and design the trial, while principal investigators manage day-to-day operations at study sites. FDA regulations require sponsors to monitor trial conduct and data integrity. Contract Research Organizations (CROs) often handle operational tasks like site selection, data management, and regulatory compliance. Collaboration among these entities ensures scientific rigor and participant safety.
Who is the father of clinical trials?
James Lind is often called the father of clinical trials for his 1747 controlled experiment on scurvy, though earlier figures like Ambroise Paré also contributed.
Lind's deliberate use of control groups and systematic comparison set a methodological precedent. Britannica credits him with establishing the template for future clinical research. Paré's 1537 battlefield observation was an important precursor, but Lind's structured approach with multiple treatment arms and a control group represents the first true clinical trial design.
What are the 4 phases of clinical trials?
The four phases of clinical trials are Phase 1 (safety and dosage), Phase 2 (efficacy and side effects), Phase 3 (large-scale efficacy and monitoring), and Phase 4 (post-marketing surveillance).
Phase 1 tests 20-100 healthy volunteers or patients for safety and pharmacokinetics. Phase 2 enrolls 100-300 patients to assess effectiveness and optimal dosing. Phase 3 involves 300-3,000+ participants to confirm efficacy, monitor adverse reactions, and compare to standard treatments. CDC explains that Phase 4 studies continue after approval to gather long-term safety data in diverse populations. Each phase must succeed before advancing.
Can you sell food without FDA approval?
Most foods do not require FDA pre-market approval, but they must comply with FDA regulations on safety, labeling, and manufacturing practices; certain food additives and novel ingredients do require pre-market review.
Under the Federal Food, Drug, and Cosmetic Act, conventional foods and dietary supplements can be marketed without FDA pre-approval, though the agency can take action against unsafe or misbranded products. FDA requires food facilities to register and follow Current Good Manufacturing Practices (CGMPs). Food additives, color additives, and substances designated as Generally Recognized as Safe (GRAS) undergo specific review processes. Imported foods must meet the same standards.
Are clinical drug trials safe?
Clinical drug trials have risks, but they are designed with multiple safeguards including institutional review boards, informed consent, and ongoing monitoring to protect participant safety.
Risks vary by phase and intervention; early-phase trials carry more uncertainty. NIH emphasizes that IRBs review protocols to minimize risks and ensure ethical conduct. Data Safety Monitoring Boards (DSMBs) independently review accumulating data and can halt trials for safety concerns. Participants receive detailed risk information before consenting and can withdraw anytime. Serious adverse events are rare but promptly reported to regulators.
Does FDA approval mean anything?
Yes, FDA approval means the agency has determined that the benefits of a drug or device outweigh its known risks for the intended use, based on rigorous review of clinical data.
Approval signifies that the product meets standards for safety, efficacy, and manufacturing quality. FDA reviewers evaluate thousands of pages of data from preclinical and clinical studies. Post-approval, the agency continues monitoring through adverse event reporting, inspections, and sometimes required Phase 4 studies. While no medical product is risk-free, FDA approval provides a science-based assurance that guides clinical decision-making.
What are the 3 phases of FDA approval?
The three phases of clinical research required for FDA approval are Phase 1 (safety), Phase 2 (efficacy), and Phase 3 (large-scale confirmation), followed by post-marketing Phase 4 surveillance.
These phases correspond to the clinical research stage of drug development. Phase 1 establishes safety and pharmacokinetics in a small group. Phase 2 explores efficacy and dose-response in patients. Phase 3 confirms effectiveness in a larger, more diverse population under real-world conditions. Mayo Clinic notes that successful completion of all three phases is typically required for a New Drug Application (NDA) or Biologics License Application (BLA). Phase 4 continues after market entry.
How long is FDA approval process?
The FDA approval process typically takes 10-15 years from discovery to market, with the clinical trial phases alone averaging 6-7 years, though accelerated pathways can shorten this for serious conditions.
Preclinical research takes 1-3 years, followed by three clinical phases. FDA review of the application adds 6-12 months under standard review, or 6 months under Priority Review. Accelerated Approval, Fast Track, Breakthrough Therapy, and Regenerative Medicine Advanced Therapy designations can expedite development and review for unmet medical needs. The COVID-19 vaccines demonstrated that emergency use authorization can compress timelines to under a year without compromising safety standards.
Who is the head of the FDA?
As of 2026, the Commissioner of the FDA is Dr. Robert Califf, who has served since February 2022.
The Commissioner is appointed by the President and confirmed by the Senate, leading the agency's regulatory and public health mission. FDA leadership also includes the Principal Deputy Commissioner and several center directors overseeing drugs, devices, food, tobacco, and other product areas. Leadership changes can occur with new administrations; verify current leadership on the FDA website for the most up-to-date information.
